RESTATED AND AMENDED MASTER CLINICAL STUDY AGREEMENTMaster Clinical Study Agreement • December 18th, 2014 • Texas
Contract Type FiledDecember 18th, 2014 Jurisdiction(this “Master Agreement”) is effective November 24, 2014 (the “Effective Date”) between GlaxoSmithKline LLC (“GSK”), and all of the following member institutions (each an “Institution”, and collectively the “Institutions”) of The University of Texas System (“System”) located at 201 West 7th Street, Austin, TX, 78701, that is governed by its Board of Regents (“Board”):